NYSE American - Delayed Quote
USD
Apimeds Pharmaceuticals US, Inc. (APUS)
3.0100
-0.2000
(-6.23%)
At close: October 30 at 4:00:00 PM EDT
2.8799
-0.1301
(-4.32%)
After hours: October 30 at 5:38:16 PM EDT
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Erik C. Emerson
|
President | 1.55M | -- | 1971 |
|
Dr. Vinod Menon
|
Founder & Co-CEO | -- | -- | 1978 |
|
Mr. Sungjoon Chae
|
Co-CEO & Director | -- | -- | 1981 |
|
Captain Sandeep Singh Yadav
|
Chief Operating Officer | -- | -- | -- |
|
Mr. Amardeep Singh
|
Chief Technology Officer | -- | -- | -- |
Apimeds Pharmaceuticals US, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Corporate Governance
Apimeds Pharmaceuticals US, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
